ETF Holdings Breakdown of RAPT
| Stock Name | RAPT Therapeutics Inc |
| Ticker | RAPT(USD) NASDAQ |
| TYPE | Common Stock |
| Country | USA |
| ISIN | US75382E1091 |
| LEI | 549300MB473BIU78ES48 |
RAPT institutional holdings
The adjusted close for RAPT on 2025-12-24 was 35.84
The following institutional investment holdings of RAPT have been identified
Book value of shares is calculated on the adjusted close price of each day (row).News associated with RAPT
- Analysts Set Rapt Therapeutics (NASDAQ:RAPT) PT at $21.57
- Rapt Therapeutics (NASDAQ:RAPT – Get Free Report) has been assigned an average rating of “Moderate Buy” from the seven brokerages that are currently covering the company, MarketBeat reports. Four investment analysts have rated the stock with a hold rating, two have issued a buy rating and one has issued a strong buy rating on the […] - 2025-08-20 03:10:52
- Two Sigma Investments LP Sells 339,957 Shares of RAPT Therapeutics, Inc. (NASDAQ:RAPT)
- Two Sigma Investments LP lowered its holdings in shares of RAPT Therapeutics, Inc. (NASDAQ:RAPT – Free Report) by 65.3% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 180,465 shares of the company’s stock after selling 339,957 shares during the period. […] - 2025-06-12 04:28:52
- Millennium Management LLC Sells 222,261 Shares of RAPT Therapeutics, Inc. (NASDAQ:RAPT)
- Millennium Management LLC cut its stake in RAPT Therapeutics, Inc. (NASDAQ:RAPT – Free Report) by 23.2% in the fourth quarter, Holdings Channel.com reports. The firm owned 737,704 shares of the company’s stock after selling 222,261 shares during the period. Millennium Management LLC’s holdings in RAPT Therapeutics were worth $1,166,000 as of its most recent filing […] - 2025-06-05 04:42:43
- RAPT Therapeutics, Inc. (NASDAQ:RAPT) Shares Sold by Two Sigma Advisers LP
- Two Sigma Advisers LP trimmed its stake in shares of RAPT Therapeutics, Inc. (NASDAQ:RAPT – Free Report) by 28.6% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 503,700 shares of the company’s stock after selling 201,300 shares during the quarter. Two Sigma Advisers […] - 2025-06-03 04:56:52
- Geode Capital Management LLC Raises Position in RAPT Therapeutics, Inc. (NASDAQ:RAPT)
- Geode Capital Management LLC lifted its stake in RAPT Therapeutics, Inc. (NASDAQ:RAPT – Free Report) by 4.9% in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 716,937 shares of the company’s stock after purchasing an additional 33,758 shares during the period. Geode Capital […] - 2025-05-01 04:30:59
- Analysts Set RAPT Therapeutics, Inc. (NASDAQ:RAPT) PT at $5.29
- RAPT Therapeutics, Inc. (NASDAQ:RAPT – Get Free Report) has earned a consensus rating of “Hold” from the nine ratings firms that are currently covering the firm, Marketbeat Ratings reports. One research analyst has rated the stock with a sell recommendation, six have issued a hold recommendation and two have given a buy recommendation to the […] - 2025-02-26 04:22:56
Back to Listing
Disclaimer
All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability for the reliability or accuracy of the data provided. We are not making recommendations for any financial instruments listed on this website.
Copyright Market Footprint Ltd. Privacy Policy
1.2%